Fauci Lauds New Merck COVID-19 Drug That Cuts Death Rate by Half
President Joe Biden's chief medical adviser told a White House press conference on Friday that "the data are impressive" on molnupiravir, developed by Big Pharma firm Merck and partner Ridgeback Biotherapeutics.
"We always hesitate to make any timelines", Fauci insisted, but added that the FDA would move "as quickly as they possibly can" to review the trial data.
"We set up 25 monoclonal antibody sites across Florida, and we’ve seen about a 70% reduction in COVID-19 hospitalizations", DeSantis wrote on his Telegram channel. "Early treatment saves lives".